BioSupply Trends Quarterly logo
Search
Close this search box.
Subscribe
Spring 2020 - Safety
  Download Issue
Share

Up Front

Publisher's Corner
Improving Patient Outcomes with Evolving Medical Models
By Patrick M. Schmidt

Features

doctor looking at an xray

Myths & Facts: Chronic Inflammation

obese child

Childhood Obesity: An Expanding Epidemic

illustration of human made up with particles

Tailor-Made Medicine: An Evolution in Precision Cures

Thermometer

The Challenge of Cold Chain Logistics

wellness

Evolving from Sick Care to Well Care

patient in wheel chair with providers nearby

The Changing Face of Primary Care

BioTrends Watch

Washington Report
CMS Launches Healthy Adult Opportunity Demonstration Initiative
Medicare Will Now Cover Acupuncture for Chronic Low Back Pain
Finalized Health Care Price Transparency Rule Unveiled
FDA Initiates Coronavirus Medical Countermeasures
NIAID Awards $30 Million to Develop Tuberculosis Vaccine
Reimbursement FAQs
CMS Price Transparency: The Basics
Healthcare Management
How to Improve Patient Satisfaction
Industry News
CDC Analyses Show Flu Vaccine Reduces Risk of Hospitalization in Children and Death in Adults
Trivalent HBV Vaccine Superior in Efficacy in Adults 45 Years and Older
Study Finds Safe Treatment for Children with Severe Hemophilia A with Inhibitors
Flu Vaccine May Reduce Risk of Heart Attack and Stroke in Hypertensive Individuals
Skin Patch Shows Promise for Delivery of Influenza Vaccine
FDA Expands Indication for Octapharma's WILATE to Hemophilia A
Researchers Uncover How Human Immunity Evades Influenza Virus
FDA Approves Sandoz's Ziextenzo as 24th Biosimilar

BioFocus

Industry Insight
Plasma-Derived ApoA-1
By Keith Berman, MPH, MBA
Patient Profile
Obesity: A Physician's Perspective
By Trudie Mitschang
Obesity: A Patient's Perspective
By Trudie Mitschang
MyFluVaccine.com

BioSources

BioResearch
FcRn Antagonist Boosts Platelet Counts, Reduces Bleeding Risk in Patients with Immune Thrombocytopenic Purpura
High-Titer Inhibitors Reduced in PUPs with Severe Hemophilia A Treated with Fourth Generation Recombinant Factor VIII
BioSupply Trends Quarterly logo
FFF Enterprises logo
Facebook-f Instagram Linkedin-in Youtube
FFF Enterprises.com | Privacy Statement | Terms of Use |

FFF Enterprises.com
Privacy Statement
Terms of Use

©2024 FFF Enterprises, Inc. All Rights Reserved. Property of FFF Enterprises, Inc.

The information provided on this website is not medical advice, nor is it intended to be a substitute for medical advice, diagnosis, and treatment. Always seek the advice of a physician or other qualified health provider with questions concerning a medical condition. Never disregard professional medical advice, or delay seeking it based on information provided on this website.